How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Natalie Harb
Advertisement
Vice President, Offering Development, Global Commercial Solutions, IQVIA
Articles by Natalie Harb
Advertisement
Latest Updated Articles
The Future of Launch Excellence is Generative AIPublished: August 15th 2024 | Updated: August 26th 2024
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5